跳至主要内容
临床试验/NL-OMON35420
NL-OMON35420招募中不适用

Pathogenesis of community-acquired pneumonia, chronic obstructive pulmonary disease and cystic fibrosis: mechanism of inflammatory response and the role of Th17 differentiation - CCCP

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 135 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • All patients with COPD, CF or CAP who are admitted to the Erasmus MC will be asked to participate in this study. The treating lung physician will assess eligibility.;COPD
  • - Age >/= 18 years
  • - Diagnosis of COPD according to GOLD criteria (FEV1/FVC<70%), classification into
  • GOLD II (FEV1 50-70% predicted) or GOLD III (FEV1 30- 50% predicted). In case of lungtransplantation: GOLD IV (FEV1 < 30% predicted).
  • - Stable disease. Patients have to be free of COPD exacerbation or respiratory tract
  • infection within a month prior to involvement in the study and they should not have received glucocorticoids or antibiotics in this period.;When patients have to undergo lungtransplantation, they will be asked whether material from their lungs can be used for this study. ;Community-acquired pneumonia
  • - Age >/= 18 years
  • - Clinical presentation of an acute illness with symptoms indicating CAP: fever, dyspnoea,
  • cough, pleuritic chest pain and new consolidations on chest X-ray have to be present.
  • - Normoxemic
  • - In case of hypoxemia (O2 saturation < 92%), patients are only included when patients are intubated and mechanically ventilated, because of respiratory insufficiency.;Cystic fibrosis
  • - Age >/= 18 years
  • - Diagnosis of CF confirmed by sweat-test and/or DNA analysis and/or
  • electrophysiology testing
  • - Stable phase (no signs of exacerbation)
  • - Exacerbation phase: characterized by signs of increased coughing, increased sputum production, dyspnea, fatigue;In some circumstances children with CF have to undergo a bronchoscopy for diagnostic reasons. In these cases we will ask the patients and/or their parents whether some extra material can be obtained from bronchoscopy for this study. Importantly, the children will not be approached to undergo a bronchoscopy, only for scientific reasons!;When patients have to undergo lungtransplantation, they will be asked whether material from their lungs can be used for this study. ;Healthy individuals
  • - Age >/= 18 years
  • - No signs of any disease
  • - Normal Lungfunction
  • - Normal Chest X-ray;In case children with CF are included with age <18 years, then age matched non-CF patients, without signs of inflammation or infection will be included as controls.

排除标准

  • - Hypoxemia (O2 saturation < 92%), unless patients are intubated and mechanically ventilated
  • - Use of antibiotics or glucocorticoids within a month prior to involvement in the study.

研究者

相似试验